The effects of the 32-bp CCR-5 deletion on HIV transmission and HIV disease progression in individuals with haemophilia.
about
Evidence of HIV exposure and transient seroreactivity in archived HIV-negative severe hemophiliac sera.CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individual.Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity.Effect of CCR5-Δ32 heterozygosity on HIV-1 susceptibility: a meta-analysis.C868T single nucleotide polymorphism and HIV type 1 disease progression among postpartum women in Kenya.Development of maraviroc, a CCR5 antagonist for treatment of HIV, using a novel tropism assay.
P2860
The effects of the 32-bp CCR-5 deletion on HIV transmission and HIV disease progression in individuals with haemophilia.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
The effects of the 32-bp CCR-5 ...... individuals with haemophilia.
@en
The effects of the 32-bp CCR-5 ...... individuals with haemophilia.
@nl
type
label
The effects of the 32-bp CCR-5 ...... individuals with haemophilia.
@en
The effects of the 32-bp CCR-5 ...... individuals with haemophilia.
@nl
prefLabel
The effects of the 32-bp CCR-5 ...... individuals with haemophilia.
@en
The effects of the 32-bp CCR-5 ...... individuals with haemophilia.
@nl
P2093
P2860
P1476
The effects of the 32-bp CCR-5 ...... individuals with haemophilia.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2141.2000.02325.X
P407
P577
2000-10-01T00:00:00Z